Nebivolol ameliorates CFA-induced adjuvant arthritis and is associated with reduced WNT5A and active β-catenin protein levels
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder characterized by synovial inflammation, cartilage destruction, bone erosion, and progressive functional impairment. Despite therapy, treatment failure and adverse effects remain major challenges. This study investigated the repurposing of nebivolol...